These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 32765682)

  • 1. Tumor suppressor REIC/Dkk-3 and its interacting protein SGTA inhibit glucocorticoid receptor to nuclear transport.
    Iwata T; Sadahira T; Ochiai K; Ueki H; Sasaki T; Haung P; Araki M; Watanabe T; Nasu Y; Watanabe M
    Exp Ther Med; 2020 Aug; 20(2):1739-1745. PubMed ID: 32765682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor suppressor REIC/DKK-3 and co-chaperone SGTA: Their interaction and roles in the androgen sensitivity.
    Ochiai K; Morimatsu M; Kato Y; Ishiguro-Oonuma T; Udagawa C; Rungsuriyawiboon O; Azakami D; Michishita M; Ariyoshi Y; Ueki H; Nasu Y; Kumon H; Watanabe M; Omi T
    Oncotarget; 2016 Jan; 7(3):3283-96. PubMed ID: 26658102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Canine REIC/Dkk-3 interacts with SGTA and restores androgen receptor signalling in androgen-independent prostate cancer cell lines.
    Kato Y; Ochiai K; Kawakami S; Nakao N; Azakami D; Bonkobara M; Michishita M; Morimatsu M; Watanabe M; Omi T
    BMC Vet Res; 2017 Jun; 13(1):170. PubMed ID: 28599655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor suppressor REIC/Dkk-3 interacts with the dynein light chain, Tctex-1.
    Ochiai K; Watanabe M; Ueki H; Huang P; Fujii Y; Nasu Y; Noguchi H; Hirata T; Sakaguchi M; Huh NH; Kashiwakura Y; Kaku H; Kumon H
    Biochem Biophys Res Commun; 2011 Aug; 412(2):391-5. PubMed ID: 21835165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression pattern of REIC/Dkk-3 in various cell types and the implications of the soluble form in prostatic acinar development.
    Zhang K; Watanabe M; Kashiwakura Y; Li SA; Edamura K; Huang P; Yamaguchi K; Nasu Y; Kobayashi Y; Sakaguchi M; Ochiai K; Yamada H; Takei K; Ueki H; Huh NH; Li M; Kaku H; Na Y; Kumon H
    Int J Oncol; 2010 Dec; 37(6):1495-501. PubMed ID: 21042718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An N-terminal 78 amino acid truncation of REIC/Dkk-3 effectively induces apoptosis.
    Abarzua F; Kashiwakura Y; Takaoka M; Watanabe M; Ochiai K; Sakaguchi M; Iwawaki T; Tanimoto R; Nasu Y; Huh NH; Kumon H
    Biochem Biophys Res Commun; 2008 Oct; 375(4):614-8. PubMed ID: 18727918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular cloning of canine co-chaperone small glutamine-rich tetratricopeptide repeat-containing protein α (SGTA) and investigation of its ability to suppress androgen receptor signalling in androgen-independent prostate cancer.
    Kato Y; Ochiai K; Michishita M; Azakami D; Nakahira R; Morimatsu M; Ishiguro-Oonuma T; Yoshikawa Y; Kobayashi M; Bonkobara M; Kobayashi M; Takahashi K; Watanabe M; Omi T
    Vet J; 2015 Nov; 206(2):143-8. PubMed ID: 26346258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenovirus-mediated overexpression of REIC/Dkk-3 selectively induces apoptosis in human prostate cancer cells through activation of c-Jun-NH2-kinase.
    Abarzua F; Sakaguchi M; Takaishi M; Nasu Y; Kurose K; Ebara S; Miyazaki M; Namba M; Kumon H; Huh NH
    Cancer Res; 2005 Nov; 65(21):9617-22. PubMed ID: 16266978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. REIC/Dkk-3 stable transfection reduces the malignant phenotype of mouse prostate cancer RM9 cells.
    Chen J; Watanabe M; Huang P; Sakaguchi M; Ochiai K; Nasu Y; Ouchida M; Huh NH; Shimizu K; Kashiwakura Y; Kaku H; Kumon H
    Int J Mol Med; 2009 Dec; 24(6):789-94. PubMed ID: 19885619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular cloning and tumour suppressor function analysis of canine REIC/Dkk-3 in mammary gland tumours.
    Ochiai K; Watanabe M; Azakami D; Michishita M; Yoshikawa Y; Udagawa C; Metheenukul P; Chahomchuen T; Aoki H; Kumon H; Morimatsu M; Omi T
    Vet J; 2013 Sep; 197(3):769-75. PubMed ID: 23732075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Properties of the feline tumour suppressor reduced expression in immortalized cells (REIC/Dkk-3).
    Ochiai K; Oda H; Shono S; Kato Y; Sugihara S; Nakazawa S; Azakami D; Michishita M; Onozawa E; Bonkobara M; Sako T; Shun-Ai L; Ueki H; Watanabe M; Omi T
    Vet Comp Oncol; 2017 Dec; 15(4):1181-1186. PubMed ID: 27353749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulation of inhibition of differentiation-1 via activation of activating transcription factor 3 and Smad regulates REIC/Dickkopf-3-induced apoptosis.
    Kashiwakura Y; Ochiai K; Watanabe M; Abarzua F; Sakaguchi M; Takaoka M; Tanimoto R; Nasu Y; Huh NH; Kumon H
    Cancer Res; 2008 Oct; 68(20):8333-41. PubMed ID: 18922905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Downregulation of the Expression of CD147 by Tumor Suppressor REIC/Dkk-3, and Its Implication in Human Prostate Cancer Cell Growth Inhibition.
    Mori A; Watanabe M; Sadahira T; Kobayashi Y; Ariyoshi Y; Ueki H; Wada K; Ochiai K; Li SA; Nasu Y
    Acta Med Okayama; 2017 Apr; 71(2):135-142. PubMed ID: 28420895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunological aspects of REIC/Dkk-3 in monocyte differentiation and tumor regression.
    Watanabe M; Kashiwakura Y; Huang P; Ochiai K; Futami J; Li SA; Takaoka M; Nasu Y; Sakaguchi M; Huh NH; Kumon H
    Int J Oncol; 2009 Mar; 34(3):657-63. PubMed ID: 19212670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cysteine-rich core domain of REIC/Dkk-3 is critical for its effect on monocyte differentiation and tumor regression.
    Kinoshita R; Watanabe M; Huang P; Li SA; Sakaguchi M; Kumon H; Futami J
    Oncol Rep; 2015 Jun; 33(6):2908-14. PubMed ID: 25823913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The expression pattern and functional role of REIC/Dkk-3 in the development of cutaneous squamous cell carcinoma.
    Shin JM; Choi DK; Kang HY; Sohn KC; Lee Y; Kim CD; Lee JH; Park BC
    J Dermatol Sci; 2016 Oct; 84(1):88-96. PubMed ID: 27354306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promising therapeutic efficacy of a novel reduced expression in immortalized cells/dickkopf-3 expressing adenoviral vector for hepatocellular carcinoma.
    Sawahara H; Shiraha H; Uchida D; Kato H; Kato R; Oyama A; Nagahara T; Iwamuro M; Horiguchi S; Tsutsumi K; Mandai M; Mimura T; Wada N; Takeuchi Y; Kuwaki K; Onishi H; Nakamura S; Watanabe M; Sakaguchi M; Takaki A; Nouso K; Yagi T; Nasu Y; Kumon H; Okada H
    J Gastroenterol Hepatol; 2017 Oct; 32(10):1769-1777. PubMed ID: 28168749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knockdown of the cochaperone SGTA results in the suppression of androgen and PI3K/Akt signaling and inhibition of prostate cancer cell proliferation.
    Trotta AP; Need EF; Selth LA; Chopra S; Pinnock CB; Leach DA; Coetzee GA; Butler LM; Tilley WD; Buchanan G
    Int J Cancer; 2013 Dec; 133(12):2812-23. PubMed ID: 23740762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of REIC/Dkk-3 suppresses the expression of CD147 and inhibits the proliferation of human bladder cancer cells.
    Horikawa Y; Watanabe M; Sadahira T; Ariyoshi Y; Kobayashi Y; Araki M; Wada K; Ochiai K; Li SA; Nasu Y
    Oncol Lett; 2017 Sep; 14(3):3223-3228. PubMed ID: 28927069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical safety and efficacy of in situ REIC/Dkk-3 gene therapy for prostate cancer.
    Kawauchi K; Watanabe M; Kaku H; Huang P; Sasaki K; Sakaguchi M; Ochiai K; Huh NH; Nasu Y; Kumon H
    Acta Med Okayama; 2012; 66(1):7-16. PubMed ID: 22358134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.